COPD trials in Sweden

In Sweden 18 Also abroad 559

18 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Where
Malmö
Age
18 years to 80 years
People
40 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00
Phase 4Taking people
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Where
Gothenburg, Lund
Age
40 years to 85 years
People
218 worldwide
Run by
Sanofi
See details and how to joinNCT07053423
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Where
Solna, Umeå
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Where
Goteborg, Karlskrona, Lund, Orebro, Solna, Stockholm
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00
Phase 3Taking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Where
Goteborg, Lund, Stockholm
Age
40 years to 80 years
People
981 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00
Phase 3Taking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Danderyd, Goteborg, Höllviken, Kungsbacka, Lund, Orebro, Solna, Stockholm, Umea, Uppsala
Age
40 years to 80 years
People
5,250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
No phaseNot yet taking people in Sweden
Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease
Where
Karlskrona
Age
18 years and over
People
120
Run by
Jacob Sandberg
See details and how to joinNCT07836764
No phaseTaking people
Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital
Where
Gothenburg
Age
18 years and over
People
200
Run by
Sahlgrenska University Hospital
See details and how to joinNCT06597331
No phaseTaking people
APP-based Medical Device for Education and Training of Inhalation Technique
Where
Boxholm, Styrsö, Uppsala
Age
16 years and over
People
80
Run by
Karolinska Institutet
See details and how to joinNCT07145632
No phaseNot yet taking people in Sweden
Home-based Pulmonary Rehabilitation for COPD Patients
Where
Stockholm
Age
40 years to 100 years
People
80
Run by
Karolinska Institutet
See details and how to joinNCT04820257
Phase 3Enrolling by invitation
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Where
Gothenburg, Malmö, Stockholm
Age
20 years to 72 years
People
290 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT02796937
No phaseTaking people
The CATALINA Study
Where
Gothenburg
Age
18 years and over
People
1,000 worldwide
Run by
Wim Janssens
See details and how to joinNCT05008081
No phaseTaking people
Multidisciplinary Management of Severe COPD
Where
Gothenburg
Age
40 years to 100 years
People
110
Run by
Vastra Gotaland Region
See details and how to joinNCT04860375
No phaseTaking people
Digital Tool for Improved Self-management of COPD
Where
Solna
Age
40 years and over
People
50
Run by
Björn Nordlund
See details and how to joinNCT07573098
No phaseEnrolling by invitation
An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
Where
Lund
Age
45 years to 75 years
People
10,000
Run by
Region Skane
See details and how to joinNCT01460264
No phaseTaking people
Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.
Where
Lund, Uppsala
Age
50 years to 85 years
People
80
Run by
Uppsala University
See details and how to joinNCT06335992
No phaseTaking people
Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
Where
Karlskrona, Örebro
Age
18 years and over
People
310
Run by
Skane University Hospital
See details and how to joinNCT06247397
No phaseTaking people
Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease
Where
Umeå
Age
60 years and over
People
208 worldwide
Run by
Umeå University
See details and how to joinNCT06068322